PMID: 16613196Apr 15, 2006Paper

Therapeutic angiogenesis for ischemic diseases

Nihon rinsho. Japanese journal of clinical medicine
Motokuni Aoki, Ryuichi Morishita

Abstract

The clinical consequences of peripheral arterial disease include pain on walking, pain at rest and loss of tissue integrity in the distal ischemic limbs. Although development of beneficial drugs and intervention devices do contribute to the treatment of this disease, critical limb ischemia is estimated to develop in 500 to 1,000 individuals per million per year. As angiogenic growth factors can stimulate the development of collateral arteries, a concept called "therapeutic angiogenesis" is now evaluated in the clinical fields. Recent progress in molecular biology has led to the development of gene therapy as a new strategy to treat a variety of cardiovascular diseases using angiogenic growth factors such as vascular endothelial growth factor (VEGF). Therapeutic angiogenesis using angiogenic growth factors is expected to be a new treatment for patients with severe ischemic heart or peripheral arterial disease.

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Hirofumi MakinoRyuichi Morishita
Experimental Physiology
Ryuichi MorishitaToshio Ogihara
Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Ryuichi Morishita
© 2022 Meta ULC. All rights reserved